SLN124
SLN124-004
Phase 2 small_molecule active
Quick answer
SLN124 for Polycythemia Vera is a Phase 2 program (small_molecule) at Silence Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Silence Therapeutics plc
- Indication
- Polycythemia Vera
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active